These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3432407)

  • 1. The effect of continuous intracerebroventricular infusion of satietin on ingestion, activity and body weight of rats.
    Bellinger LL; Mendel VE
    Physiol Behav; 1987; 41(5):505-9. PubMed ID: 3432407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebroventricular infusions of rat satietin into rats does not produce conditioned taste aversion.
    Bellinger LL; Mendel VE
    Physiol Behav; 1987; 41(5):511-4. PubMed ID: 3432408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ingestion, body weight and activity of rats receiving repeated intracerebroventricular infusions of rat satietin.
    Bellinger LL; Mendel VE
    Physiol Behav; 1988; 44(4-5):445-52. PubMed ID: 3237837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Satietin: route of injection, dose response, effect on food and water intake and on running-wheel activity in the rat.
    Mendel VE; Bellinger LL; Williams FE; Iredale RA
    Pharmacol Biochem Behav; 1986 Feb; 24(2):247-51. PubMed ID: 3952114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human satietin: rapid development of tolerance and its specificity to feeding behavior in rats.
    Mendel VE; Benitez RR; Tetzke TA
    Pharmacol Biochem Behav; 1988 Sep; 31(1):21-6. PubMed ID: 3252253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intracerebroventricularly infused satietin on conditioned taste aversion and feeding in rats fasted different lengths.
    Bellinger LL; Mendel VE
    Pharmacol Biochem Behav; 1985 Oct; 23(4):559-66. PubMed ID: 4070333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood profile and balance study of rats given the putative anorectic agent satietin.
    Bellinger LL; Mendel VE
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R1-7. PubMed ID: 7840308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPLC-purified bovine satietin suppresses food intake and weight without causing conditioned taste aversion.
    Bellinger LL; Nagy J; Hamilton J
    Pharmacol Biochem Behav; 1994 Mar; 47(3):659-66. PubMed ID: 8208786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPLC-purified human satietin does not produce conditioned taste aversion in rats.
    Bellinger LL; Mendel VE
    Pharmacol Biochem Behav; 1991 May; 39(1):161-5. PubMed ID: 1924498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of semi- and HPLC-purified human satietin and alpha-1-glycoprotein on ingestion and body weight.
    Bellinger LL; Mendel VE
    Brain Res Bull; 1990 Dec; 25(6):941-7. PubMed ID: 2289176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of components derived from HPLC purification of human satietin on ingestion, body weight, and taste aversion in the rat.
    Bellinger LL; Mendel VE
    Pharmacol Biochem Behav; 1994 Feb; 47(2):255-63. PubMed ID: 8146216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The selectivity of the anorectic effect of satietin. II. Ineffectiveness of satietin on the water intake in food deprived rats. Effect of satietin in "conditioned aversion" paradigm.
    Sándor G; Knoll J
    Pol J Pharmacol Pharm; 1982; 34(1-3):25-32. PubMed ID: 7167419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The time-structure of the anorectic effect of satietin.
    Sándor G; Knoll J
    Physiol Behav; 1985 May; 34(5):851-3. PubMed ID: 4034724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ingestive response shows absence of taste aversion after bovine satietin in rats.
    Hamilton J; Cabanac M; Lafrance L; Nagy J
    Physiol Behav; 1995 Jan; 57(1):125-8. PubMed ID: 7878104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selectivity of the anorectic effect of satietin. I. The ineffectiveness of satietin on behavioral tests.
    Knoll B; Knoll J
    Pol J Pharmacol Pharm; 1982; 34(1-3):17-23. PubMed ID: 7167418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Satietin: a centrally acting potent anorectic substance with a long-lasting effect in human and mammalian blood.
    Knoll J
    Pol J Pharmacol Pharm; 1982; 34(1-3):3-16. PubMed ID: 7167420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Satietin; a 50,000 dalton glycoprotein in human serum with potent, long-lasting and selective anorectic activity.
    Knoll J
    J Neural Transm; 1984; 59(3):163-94. PubMed ID: 6376708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of anorexigenic peptide injected into the brain: dissociation of effect on body weight and feeding in the rat.
    Myers RD; Hepler JR; Holahan W
    Peptides; 1983; 4(1):85-8. PubMed ID: 6866812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Satietin, a blood-borne anorectic glycoprotein, as the putative rate-limiting satiety signal in the negative feed-back of food intake.
    Knoll J
    Z Ernahrungswiss; 1984 Jun; 23(2):85-103. PubMed ID: 6475142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic intraventricular administration of cholecystokinin octapeptide (CCK-8) suppresses feeding in rats.
    Schick RR; Stevens CW; Yaksh TL; Go VL
    Brain Res; 1988 May; 448(2):294-8. PubMed ID: 3378151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.